| 1 |
Ayano G, Demelash S, Gizachew Y, et al. The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses [J]. J Affect Disord, 2023, 339: 860-866.
|
| 2 |
Liu Y, Zhang P, Sun H. A narrative review of research advances in gut microbiota and microecological agents in children with attention deficit hyperactivity disorder (ADHD) [J]. Front Psychiatry, 2025, 16: 1588135.
|
| 3 |
You M, Chen N, Yang Y, et al. The gut microbiota-brain axis in neurological disorders [J]. MedComm, 2024, 5(8): e656.
|
| 4 |
Li Y, Sun H, Huang Y, et al. Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus-associated host cognitive impairment [J]. Gut Microbes, 2022, 14(1): 2125747.
|
| 5 |
Wang X, Wang N, Gao T, et al. Symptom-specific gut microbial and metabolic profiles in ADHD reveal SCFA deficiency as a Key pathogenic mechanism [J]. Gut Microbes, 2025, 17(1): 2537755.
|
| 6 |
Wang N, Wang H, Bai Y, et al. Metagenomic analysis reveals difference of gut microbiota in ADHD [J]. J Atten Disord, 2024, 28(5): 872-879.
|
| 7 |
Steckler R, Magzal F, Kokot M, et al. Disrupted gut harmony in attention-deficit/hyperactivity disorder: Dysbiosis and decreased short-chain fatty acids [J]. Brain, Behav Immun Health, 2024, 40: 100829.
|
| 8 |
Xiao L, Liu S, Wu Y, et al. The interactions between host genome and gut microbiome increase the risk of psychiatric disorders: Mendelian randomization and biological annotation [J]. Brain Behavior Immun, 2023, 113: 389-400.
|
| 9 |
Fock E, Parnova R. Mechanisms of blood-brain barrier protection by microbiota-derived short-chain fatty acids [J]. Cells, 2023, 12(4): 657.
|
| 10 |
Caetano-Silva MEl, Rund L, Hutchinson NT, et al. Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids [J]. Sci Rep, 2023, 13(1): 2819.
|
| 11 |
Molska M, Mruczyk K, Cisek-Woźniak A, et al. The influence of intestinal microbiota on BDNF levels [J]. Nutrients, 2024, 16(17): 2891.
|
| 12 |
Boonchooduang N, Louthrenoo O, Likhitweerawong N, et al. Impact of psychostimulants on microbiota and short-chain fatty acids alterations in children with attention-deficit/hyperactivity disorder [J]. Sci Rep, 2025, 15(1): 3034.
|
| 13 |
Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity [J]. Cell Mol Immunol, 2023, 20(4): 341-350.
|
| 14 |
Krajewski K. Heavy metals, noradrenaline/adrenaline ratio, and microbiome-associated hormone precursor metabolites: biomarkers for social behaviour, ADHD symptoms, and executive function in children [J]. Sci Rep, 2025, 15(1): 19006.
|
| 15 |
Sağlam E, Bilgiç A, Abuşoğlu S, et al. The role of tryptophan metabolic pathway in children with attention deficit hyperactivity disorder with and without comorbid oppositional defiant disorder and conduct disorder [J]. Psychiatry Res, 2021, 298: 113770.
|
| 16 |
Dinu LM, Singh SN, Baker NS, et al. The effects of tryptophan loading on Attention Deficit Hyperactivity Disorder in adults: A remote double blind randomised controlled trial [J]. PloS one, 2023, 18(11): e0294911.
|
| 17 |
Bundgaard-Nielsen C, Lauritsen MB, Knudsen JK, et al. Children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorder share distinct microbiota compositions [J]. Gut Microbes, 2023, 15(1): 2211923.
|
| 18 |
Misiak B, Wójta-Kempa M, Samochowiec J, et al. Peripheral blood inflammatory markers in patients with attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2022, 118: 110581.
|
| 19 |
Corona JC. Role of oxidative stress and neuroinflammation in attention-deficit/hyperactivity disorder [J]. Antioxidants (Basel, Switzerland), 2020, 9(11): 1039.
|
| 20 |
Garre-Morata L, de Haro T, Villén RG, et al. Changes in cortisol and in oxidative/nitrosative stress indicators after ADHD treatment [J]. Antioxidants (Basel, Switzerland), 2024, 13(1): 92.
|
| 21 |
Wang LJ, Li SC, Li SW, et al. Gut microbiota and plasma cytokine levels in patients with attention-deficit/hyperactivity disorder [J]. Transl Psychiatry, 2022, 12(1): 76.
|
| 22 |
Hamed R, Elmalt H, Salama A, et al. MMP-2, MMP-9, TNF-α levels in relation to sub types of attention deficit hyperactivity disorder [J]. Biomed Pharmacol J, 2021, 14(2):541-548.
|
| 23 |
Gustafsson HC, Dunn G, Mitchell AJ, et al. The association between heightened ADHD symptoms and cytokine and fatty acid concentrations during pregnancy [J]. Front Psychiatry, 2022, 13: 855265.
|
| 24 |
Yang LL, Stiernborg M, Skott E, et al. Effects of a synbiotic on plasma immune activity markers and short-chain fatty acids in children and adults with ADHD-A randomized controlled trial [J]. Nutrients, 2023, 15(5): 1293.
|
| 25 |
Guo N, Lv LL. Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis [J]. Immun Inflamm Dis, 2023, 11(10): e1045.
|
| 26 |
Mustika D, Nishimura Y, Ueno S, et al. Central amygdala is related to the reduction of aggressive behavior by monosodium glutamate ingestion during the period of development in an ADHD model rat [J]. Front Nutr, 2024, 11: 1356189.
|
| 27 |
Tette FM, Kwofie SK, Wilson MD. Therapeutic anti-depressant potential of microbial GABA produced by lactobacillus rhamnosus strains for GABAergic signaling restoration and inhibition of addiction-induced HPA axis hyperactivity [J]. Curr Issues Mol Biol, 2022, 44(4): 1434-1451.
|
| 28 |
Nayok SB, Sreeraj VS, Shivakumar V, et al. A primer on interoception and its importance in psychiatry [J]. Clin Psychopharmacol Neurosci, 2023, 21(2): 252-261.
|
| 29 |
Neuser MP, Teckentrup V, Kühnel A, et al. Vagus nerve stimulation boosts the drive to work for rewards [J]. Nat Commun, 2020, 11(1): 3555.
|
| 30 |
Castro Ribeiro T, García Pagès E, Huguet A, et al. Physiological parameters to support attention deficit hyperactivity disorder diagnosis in children: a multiparametric approach [J]. Front Psychiatry, 2024, 15: 1430797.
|
| 31 |
Fulun L, Yanan L, Bing G, et al. Hypothalamic-pituitary-adrenal axis dysfunction in children with ADHD: A systematic review and meta-analysis [J]. Psychoneuroendocrinology, 2025, 181: 107605.
|
| 32 |
Berens A, LeMoult J, Kircanski K, et al. ADHD symptoms and diurnal cortisol in adolescents: The importance of comorbidities [J]. Psychoneuroendocrinology, 2023, 148: 105990.
|
| 33 |
Pelsser L, Stobernack T, Frankena K. Physical complaints decrease after following a few-foods diet in children with ADHD [J]. Nutrients, 2022, 14(15): 3036.
|
| 34 |
Hontelez S, Stobernack T, Pelsser LM, et al. Correlation between brain function and ADHD symptom changes in children with ADHD following a few-foods diet: an open-label intervention trial [J]. Sci Rep, 2021, 11(1): 22205.
|
| 35 |
San Mauro Martin I, Sanz Rojo S, González Cosano L, et al. Impulsiveness in children with attention-deficit/hyperactivity disorder after an 8-week intervention with the Mediterranean diet and/or omega-3 fatty acids: a randomised clinical trial [J]. Neurologia (Barcelona, Spain), 2022, 37(7): 513-523.
|
| 36 |
Khoshbakht Y, Moghtaderi F, Bidaki R, et al. The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial [J]. Eur J Nutr, 2021, 60(7): 3647-3658.
|
| 37 |
Lertxundi N, Molinuevo A, Valvi D, et al. Dietary inflammatory index of mothers during pregnancy and Attention Deficit-Hyperactivity Disorder symptoms in the child at preschool age: a prospective investigation in the INMA and RHEA cohorts [J]. Eur Child Adolesc Psychiatry, 2022, 31(4): 615-624.
|
| 38 |
Ast HK, Hammer M, Zhang S, et al. Gut microbiome changes with micronutrient supplementation in children with attention-deficit/hyperactivity disorder: the MADDY study [J]. Gut Microbes, 2025, 17(1): 2463570.
|
| 39 |
Robinette LM, Hatsu IE, Johnstone JM, et al. Treatment response to supplemental nutrients for ADHD is independent of diet quality: the MADDY Study RCT [J]. Nutr Neurosci, 2024, 27(4): 319-328.
|
| 40 |
Liu Y, Yang C, Meng Y, et al. Ketogenic diet ameliorates attention deficit hyperactivity disorder in rats via regulating gut microbiota [J]. PloS One, 2023, 18(8): e0289133.
|
| 41 |
Thorsteinsdottir S, Njardvik U, Bjarnason R, et al. Changes in eating behaviors following taste education intervention: focusing on children with and without neurodevelopmental Disorders and their families: A randomized controlled trial [J]. Nutrients, 2022, 14(19): 4000.
|
| 42 |
Wang LJ, Yang CY, Kuo HC, et al. Effect of Bifidobacterium bifidum on clinical characteristics and gut microbiota in attention-deficit/hyperactivity disorder [J]. J Pers Med, 2022, 12(2): 227.
|
| 43 |
Wang LJ, Tsai CS, Chou WJ, et al. Add-On bifidobacterium bifidum supplement in children with attention-deficit/hyperactivity disorder: A 12-week randomized double-blind placebo-controlled clinical trial [J]. Nutrients, 2024, 16(14): 2260.
|
| 44 |
Levy Schwartz M, Magzal F, Yehuda I, et al. Exploring the impact of probiotics on adult ADHD management through a double-blind RCT [J]. Sci Rep, 2024, 14(1): 26830.
|
| 45 |
Lawrence K, Fibert P, Toribio-Mateas M, et al. Effects of kefir on symptoms, sleep, and gut microbiota in children with ADHD: a randomised controlled trial [J]. BMC Psychiatry, 2025, 25(1): 1117.
|
| 46 |
Elhossiny RM, Elshahawy HH, Mohamed HM, et al. Assessment of probiotic strain Lactobacillus acidophilus LB supplementation as adjunctive management of attention-deficit hyperactivity disorder in children and adolescents: a randomized controlled clinical trial [J]. BMC Psychiatry, 2023, 23(1): 823.
|
| 47 |
Sangsefidi ZS, Sangsefidi ZS, Moharreri F, et al. Effect of probiotics as an adjunctive therapy with Ritalin among ADHD children and adolescents: a triple-blind randomized controlled trial [J]. Nutr Neurosci, 2025, 28(4): 522-531.
|
| 48 |
Hooi SL, Dwiyanto J, Rasiti H, et al. A case report of improvement on ADHD symptoms after fecal microbiota transplantation with gut microbiome profiling pre- and post-procedure [J]. Curr Med Res Opin, 2022, 38(11): 1977-1982.
|